These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 14057448)

  • 1. [CONTROLLED TUBERCULOSTATIC THERAPY IN PREVIOUSLY UNTREATED TUBERCULOSIS].
    SABLJICA B; RAJCEVIC V
    Tuberkulosearzt; 1963 Aug; 17():514-9. PubMed ID: 14057448
    [No Abstract]   [Full Text] [Related]  

  • 2. [OUR EXPERIENCE WITH THE TREATMENT OF PULMONARY TUBERCULOSIS RESISTANT TO CLASSICAL TUBERCULOSTATIC DRUGS].
    KOVACEVIC M; MILUTINOVIC R; KONJOVIC M; ZIGIC M
    Tuberkuloza; 1963; 15():250-3. PubMed ID: 14067279
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL SIGNIFICANCE OF PRIMARY RESISTANCE TO TUBERCULOSTATIC DRUGS].
    POPOVIC J; PESIC V; DAVIDOVIC C; BJEGOVIC M; JOVANOVIC M; PRASO R
    Tuberkuloza; 1963; 15():245-9. PubMed ID: 14067278
    [No Abstract]   [Full Text] [Related]  

  • 4. [The choice of drug to be combined with INH in the initial drug therapy of tuberculosis patients].
    BOSZORMENYI M; FAUSZT I; BARABAS M; BARAT I; JAKAB Z; MAJZIK G; SCHWEIGER O
    Tuberkulozis; 1962 Dec; 15():360-4. PubMed ID: 14014238
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pyrazinamide in association with streptomycin, PAS and isoniazid in the therapy of pulmonary tuberculosis].
    TODOROFF T; FRANZOSI P
    Minerva Med; 1962 Sep; 53():2667-73. PubMed ID: 13985260
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood concentration of basic tuberculostatic preparations with single administration of daily doses in pulmonary tuberculosis].
    Kanevskaia SS
    Probl Tuberk; 1970; 48(10):54-8. PubMed ID: 5496751
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 8. [FURTHER CONTRIBUTIONS TO THE DRUG THERAPY OF AN ADULT TYPE OF PULMONARY TUBERCULOSIS IN ADOLESCENTS ISONIAZID PLUS PYRAZINAMIDE THERAPY].
    GOERGENYI O; SZOCSKA M
    Tuberk Tudobetegsegek; 1963; 16():100-5. PubMed ID: 14054909
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON HEPATITIS IN PULMONARY TUBERCULOSIS PATIENTS].
    ZADOR A; NAGY G; GEVICSER P; KLIMENKO O
    Tuberk Tudobetegsegek; 1963; 16():147-9. PubMed ID: 14054916
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of irregular use of antitubercular medication by outpatients on the effectiveness of subsequent sanatorial therapy].
    VARGA J
    Tuberkulozis; 1962 Nov; 15():350-2. PubMed ID: 13996308
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of the immunological tests in the diagnosis of adverse effects of tuberculostatic therapy].
    Averbakh MM; Keleberda KIa; Gergert VIa; Mingazitinova DM
    Probl Tuberk; 1980 Mar; (3):27-30. PubMed ID: 6994091
    [No Abstract]   [Full Text] [Related]  

  • 14. COMBINED DRUG THERAPY OF PULMONARY TUBERCULOSIS.
    BOESZOERMENYI M; FAUSZT I; KANITZ E; SCHWEIGER O
    Ther Hung; 1963; 12():9-14. PubMed ID: 14059821
    [No Abstract]   [Full Text] [Related]  

  • 15. A triple regimen of streptomycin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 2.
    Oka S; Kayaba K
    Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):106-9. PubMed ID: 5525311
    [No Abstract]   [Full Text] [Related]  

  • 16. [Directions for the treatment of children with primary pulmonary and hilar lymph node tuberculosis].
    van ZEBEN ; van der DRIFT
    Maandschr Kindergeneeskd; 1963 Jan; 31():3-25. PubMed ID: 14003349
    [No Abstract]   [Full Text] [Related]  

  • 17. [Primary drug resistance to standard drugs in previously untreated patients with pulmonary tuberculosis in Poznań in 1966-1969].
    Krzyzaniak J; Lubieńska B
    Gruzlica; 1971 Aug; 39(8):742-6. PubMed ID: 5097535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 19. Canadian survey to determine the rate of drug resistance to isoniazid, PAS and streptomycin in newly detected untreated tuberculosis patients and retreatment cases.
    Hershfield ES; Eidus L; Helbecque DM
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):387-93. PubMed ID: 115802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of treatment by a combination of thiocarlide and isoniazid in previously untreated pulmonary tuberculosis].
    Aksüğür H; Gülbaran R; Cakirca R
    Poumon Coeur; 1967; 23(6):729-38. PubMed ID: 6070030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.